In a world where mental health challenges continue to rise, one Nigerian-born scientist is making groundbreaking strides in psychiatric research and clinical care. Oluwagbenga Dada’s remarkable journey from humble beginnings in Nigeria to a globally recognised expert in psychiatry is a compelling story of determination, resilience, and purpose.

Born into a family deeply rooted in the medical profession, Dada’s passion for mental health research was ignited early. His father, a respected psychiatrist and former Permanent Secretary of the Ministry of Health in Ogun State, played a pivotal role in inspiring his career path. Witnessing his father’s dedication to healthcare reforms and patient welfare planted the seeds for Dada’s own aspirations.

Determined to follow this legacy of service, Dada embarked on a journey of academic excellence. He obtained a degree in Biochemistry from Babcock University and proceeded to earn a master’s degree in Biochemistry from the University of Ibadan. However, his relentless pursuit of knowledge and impact soon took him beyond Nigeria’s borders.

His outstanding academic achievements opened doors to a prestigious research position at the Institute of Medical Science, University of Toronto. At North America’s largest mental health research facility—the Centre for Addiction and Mental Health (CAMH)—Dada delved into groundbreaking studies under the mentorship of the distinguished psychiatrist Dr. Vincenzo De Luca. Recognising his exceptional potential, CAMH honoured Dada with the Cleghorn Award, a prestigious grant that funded his innovative research efforts.

Dada’s research has since illuminated critical insights into the relationship between stress and suicidal ideation in schizophrenia. His landmark study, Mediating Effect of Genome-Wide DNA Methylation on Suicidal Ideation Induced by Perceived Stress, identified a pivotal genetic marker, cg10782349 in the ZNF701 gene on chromosome 19. This discovery revealed how DNA hypermethylation in response to stress can influence suicidal thoughts, offering new hope for improved mental health treatments.

Dada’s contributions have gained global recognition. He has presented his findings at esteemed international conferences, including:
Effect of Adverse Life Events on Global Methylation and Perceived Stress in Schizophrenia at the 74th Annual Meeting of the Society of Biological Psychiatry.

Analysis of Methylation Age and Blood Cell Composition in Subjects with Current Suicide Ideation at the Schizophrenia Bulletin conference.

Copy Number Variance (CNV) Analysis to Determine Optimal Antipsychotic Dosage in Schizophrenia: A Pilot Study presented at the Schizophrenia Bulletin symposium.

Not content with limiting his impact to research alone, Dada has taken strides to merge science with clinical care. He pursued medical training at Rocky Vista University College of Osteopathic Medicine in the United States, where his dedication earned him the prestigious RVU Opportunity Scholarship, a $40,000 grant awarded to students from underserved communities.

Driven by an unwavering commitment to improving mental health outcomes, Dada’s ultimate goal is to become a physician-scientist. By combining research innovation with clinical expertise, he aims to revolutionise psychiatric care, particularly for marginalised and underserved populations worldwide.

Oluwagbenga Dada’s inspiring journey is a powerful reminder that resilience, mentorship, and dedication can fuel extraordinary achievements. His work is not only reshaping the understanding of psychiatric disorders but also illuminating a path toward more effective, personalised treatments for mental health conditions across the globe.